topiramate

NDC 51655-746 · Northwind Health Company, LLC

Generic nametopiramate

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength50 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryANDA

Packages

51655-746-26 — 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-746-26)

51655-746-52 — 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-746-52)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

50458-640 — topiramate, 50458-641 — topiramate, 50458-642 — topiramate, 50458-645 — topiramate, 50458-647 — topiramate, 51407-893 — Topiramate, 51407-894 — Topiramate, 51655-429 — topiramate, 51655-606 — Topiramate, 51655-608 — Topiramate, 51655-848 — topiramate, 52652-9001 — Topiramate, 55154-7142 — topiramate, 55154-7146 — topiramate, 59651-452 — TOPIRAMATE, 59651-453 — TOPIRAMATE, 60760-075 — topiramate, 60760-577 — topiramate, 60760-752 — topiramate, 61919-213 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels